ELYVOPE
DEAD

Serial Number

90906331

Owner

ACADIA Pharmaceuticals, Inc.

Attorney

Carissa L. Weiss

Filing Date

Aug 27, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ELYVOPE Trademark

Serial Number: 90906331

ELYVOPE is a trademark filed by ACADIA Pharmaceuticals, Inc. on August 27, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

ACADIA Pharmaceuticals, Inc.

12830 El Camino Real, Suite 400
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

August 27, 2021

Registration Date

Not Registered

Published for Opposition

January 24, 2023

Goods & Services

Medical consulting with respect to neurologic, genetic, psychologic, and psychiatric diseases and disorders, including Rett syndrome and its identification and treatment; providing online information for health care providers, caregivers, and patients in the field of neurologic, genetic, psychologic, and psychiatric diseases and disorders; medical informational support services, namely, providing information about the benefits of diagnostic tools, medical information regarding disease diagnosis, identification, treatment, and management, and healthcare-related information to patients, caregivers, and healthcare professionals all related to neurologic, genetic, psychologic, and psychiatric diseases and disorders

Pharmaceuticals for use in the prevention and treatment of neurologic, genetic, psychologic, and psychiatric diseases and disorders

Scientific and industrial biotechnological and biomedical research; chemical, biochemical and molecular biological analyses; medical testing in the nature of pharmaceutical testing, namely, in vitro and in vivo preclinical testing of potential drugs; and consultation related to all the foregoing services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Promoting awareness of patient support offerings for neurologic, genetic, psychologic, and psychiatric diseases and disorders; business administrative services for medical referrals

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 27, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 27, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 27, 2026 EXRA
SOU EXTENSION 5 GRANTED
Jan 26, 2026 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 26, 2026 AITU
SOU TEAS EXTENSION RECEIVED
Sep 5, 2025 EEXT
SOU EXTENSION 5 FILED
Sep 4, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2025 EXRA
SOU EXTENSION 4 GRANTED
Mar 20, 2025 EX4G
SOU EXTENSION 4 FILED
Mar 19, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 19, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 4, 2024 EXRA
SOU EXTENSION 3 GRANTED
Sep 4, 2024 EX3G
SOU EXTENSION 3 FILED
Sep 4, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Sep 4, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2024 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 22, 2024 EXRA
SOU EXTENSION 2 GRANTED
Mar 21, 2024 EX2G
SOU EXTENSION 2 FILED
Mar 21, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 21, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 24, 2023 EXRA
SOU EXTENSION 1 GRANTED
Aug 22, 2023 EX1G
SOU EXTENSION 1 FILED
Aug 22, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 22, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 21, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 20, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 20, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 20, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 20, 2022 CNEA
EXAMINER'S AMENDMENT ENTERED
Nov 30, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 30, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 30, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 30, 2022 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 30, 2021 NWOS
NEW APPLICATION ENTERED
Aug 31, 2021 NWAP